+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

From
From
Cosmetic Surgery Global Market Report 2024 - Product Thumbnail Image

Cosmetic Surgery Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
STAT Inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

STAT Inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 150 Pages
  • Global
From
From
CAR-T Therapy Pipeline Analysis Global Market Report 2023 - Product Thumbnail Image

CAR-T Therapy Pipeline Analysis Global Market Report 2023

  • Report
  • February 2023
  • 175 Pages
  • Global
From
Pompe Disease Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Pompe Disease Treatment Market Report and Forecast 2023-2031

  • Report
  • March 2023
  • 147 Pages
  • Global
From
Beta-1 Receptors Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Beta-1 Receptors Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Epidermal growth factor receptor antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

Epidermal growth factor receptor antagonists - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
From
Gene Therapy-Competitive landscape, 2023 - Product Thumbnail Image

Gene Therapy-Competitive landscape, 2023

  • Report
  • May 2023
  • 450 Pages
  • Global
From
From
From
Loading Indicator